BeckerSmith Medical, Inc. v. Quinton Bickley

District Court, C.D. California·Decided January 26, 2023·No. 8:22-cv-02072·Unknown

Opinion

Case 8:22-cv-02072-CJC-ADS Document 26 Filed 01/26/23 Page 1 of 10 Page ID #:1136

JS-6

) BECKERSMITH MEDICAL, INC., ) Case No.: SACV 22-02072-CJC (ADSx) ) ) Plaintiff, ) ) v. ) ORDER GRANTING PLAINTIFF’S ) MOTION TO REMAND AND ) DENYING REQUEST FOR QUINTON BICKLEY, MARSHALL ) SANCTIONS [Dkt. 19] ) FRYMAN, and DOES 1 through 100, ) inclusive, ) ) ) Defendants. ) ) ) ) )

I. INTRODUCTION

On July 7, 2021, Plaintiff BeckerSmith Medical, Inc. (“BSM”) filed this action against Defendants Quinton Bickley and Marshall Fryman in the Superior Court of California, County of Orange, alleging that Defendants “conspired together to weaponize the knowledge of BSM’s confidential information against BSM either for the purpose of -1- Case 8:22-cv-02072-CJC-ADS Document 26 Filed 01/26/23 Page 2 of 10 Page ID #:1137

leveraging a better deal with BSM or for the purpose of disrupting and interfering with BSM’s business in retaliation for BSM’s refusal to acquiesce to their demands.” (Dkt. 1- 1 [Complaint] ¶ 14.) Now before the Court is Defendants’ motion to remand and request for sanctions. (Dkt. 19.) For the following reasons, the Court GRANTS the motion to remand and DENIES the request for sanctions.1 A. Factual Background BSM is a medical device developer that focuses on products that monitor, analyze, and manage Cerebral Spinal Fluid (“CSF”) drainage. (Dkt. 1-33 [Second Amended Complaint, hereinafter “SAC”] ¶ 7.) “For over ten years, Plaintiff has been working on a life-saving CSF device that revolutionizes CSF drainage, monitoring, and analysis through automation and other confidential and proprietary technology.” (Id.) Bickley, who worked with BSM from 2013 to 2021 and used to be BSM’s Chief Executive Officer, signed a nondisclosure agreement and a consulting agreement with BSM. (Id. ¶ 8.) In 2020, he began working with Fryman, giving him BSM’s confidential or proprietary information after Fryman signed a nondisclosure agreement that Bickley did not tell BSM about. (Id. ¶ 12.) Bickley asked Fryman to use the confidential or proprietary information “to prepare patents for BSM, to work to develop CSF products for BSM, and to participate in strategizing about fundraising, marketing, and business matters for BSM.” (Id.) In doing so, Bickley did not “adequately protect[] BSM’s confidential and proprietary information or BSM’s best interests.” (Id.)

1 Having read and considered the papers presented by the parties, the Court finds this matter appropriate for disposition without a hearing. See Fed. R. Civ. P. 78; Local Rule 7-15. Accordingly, the hearing set for January 30, 2023, is hereby vacated and removed from the calendar. -2- Case 8:22-cv-02072-CJC-ADS Document 26 Filed 01/26/23 Page 3 of 10 Page ID #:1138

In spring 2021, BSM renegotiated its contract with Bickley. (Id. ¶ 14.) During those negotiations, Bickley asked BSM to give Fryman a substantial equity stake in BSM, but BSM was reticent because it believed “it needed to first get more familiar with” Fryman. (Id. ¶¶ 14–15.) Although BSM and Bickley “shook on” a deal on May 27, 2021, less than a week later Bickley “abruptly informed BSM that both he and Fryman were terminating their relationship with BSM.” (Id. ¶ 15.) “Bickley and Fryman then conspired together to weaponize their knowledge of [BSM’s] confidential information against [BSM] either for the purpose of leveraging a better deal with [BSM] or for the purpose of disrupting and interfering with [BSM’s] business in retaliation for Plaintiff’s refusal to acquiesce to their demands.” (Id. ¶ 16.) For example, Fryman filed a provisional patent application pertaining to projects he had been working on for BSM, which contained BSM’s confidential and proprietary information. (Id. ¶ 17.) On June 15, 2021, Fryman’s attorney sent BSM, its manufacturing partner Gilero, and a BSM consultant, LMG Corp., a letter asserting that BSM was using Fryman’s intellectual property without authorization. (Id. ¶¶ 18–19.) Both Gilero and LMG Corp. stopped working with BSM because of these letters. (Id. ¶ 21.) A company administering a crowdfunding-type investment program for technology companies also rescinded its offer for BSM to participate in its program based on Fryman’s claims. (Id. ¶ 22.) In this case, BSM asserts claims for (1) breach of Bickley’s NDA, (2) breach of Bickley’s consulting agreement, (3) breach of fiduciary duty for failure to use reasonable care against Bickley, (4) breach of the duty of loyalty against Bickley, (5) breach of the duty of confidentiality against Bickley, (6) indemnification against Bickley, (7) breach of Fryman’s NDA, (8) intentional interference with contractual relations against both -3- Case 8:22-cv-02072-CJC-ADS Document 26 Filed 01/26/23 Page 4 of 10 Page ID #:1139

Bickley and Fryman, (9) intentional interference with prospective economic advantage against both Bickley and Fryman, (10) unjust enrichment against both Bickley and Fryman, (11) an accounting against both Bickley and Fryman, and (12) trade secret misappropriation under the California Uniform Trade Secrets Act (“CUTSA”) against both Bickley and Fryman. (Id. ¶¶ 27–94.) Among other relief, BSM seeks damages, injunctive relief, and fees. (Id. at 21–22.) As to injunctive relief, BSM seeks an injunction preventing Fryman and Bickley from “patenting, manufacturing, making, distributing, marketing, offering to sell or selling products that utilize, embody, or were developed using” BSM’s confidential or proprietary information, disclosing BSM’s confidential or proprietary information, or offering to sell or selling any products using BSM’s confidential or proprietary information. (Id. at 20.) B. Procedural Background BSM first filed this action in state court in July 2021, alleging claims for (1) breach of contract, (2) breach of fiduciary duty, (3) indemnification, (4) intentional interference with contractual relations and (5) prospective economic advantage, (6) unjust enrichment, and (7) an accounting. On September 7, 2021, Defendants filed an answer. (Dkt. 1 [Notice of Removal, hereinafter “NOR”] ¶ 3.) On October 19, 2021, BSM filed a First Amended Complaint (“FAC”) adding an additional breach of contract claim against Bickley. (Id. ¶ 4.) On November 29, 2021, Defendants filed an answer to the FAC, and Bickley filed a cross-complaint against BSM alleging six claims arising out of Bickley’s former employment relationship with BSM. (Id. ¶ 5.) The parties engaged in an unsuccessful mediation in early 2022 and further discovery during the first half of 2022. (Id. ¶ 7.) -4- Case 8:22-cv-02072-CJC-ADS Document 26 Filed 01/26/23 Page 5 of 10 Page ID #:1140

Free access — add to your briefcase to read the full text and ask questions with AI

BeckerSmith Medical, Inc. v. Quinton Bickley, (C.D. Cal. 2023).

BeckerSmith Medical, Inc. v. Quinton Bickley (BeckerSmith Medical, Inc. v. Quinton Bickley) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Eberhart v. United States
546 U.S. 12 (Supreme Court, 2005)
Martin v. Franklin Capital Corp.
546 U.S. 132 (Supreme Court, 2005)
Gunn v. Minton
133 S. Ct. 1059 (Supreme Court, 2013)
Lussier v. Dollar Tree Stores, Inc.
518 F.3d 1062 (Ninth Circuit, 2008)
Laura Jordan v. Nationstar Mortgage LLC
781 F.3d 1178 (Ninth Circuit, 2015)
Harvey v. Shalala
19 F.3d 1252 (Eighth Circuit, 1994)